29.03.2018 • NewsDede WillamsPlastics and Polymers

Polyplastics USA to Incorporate TOPAS

Polyplastics USA to Incorporate TOPAS (c) Srebrina Yaneva
Polyplastics USA to Incorporate TOPAS (c) Srebrina Yaneva

Polyplastics USA, a subsidiary of Japanese-engineering plastics producer Polyplastics, plans to incorporate its US affiliate TOPAS Advanced Polymers (TAP USA) with effect from Apr. 1. The merger will add TOPAS’ portfolio of cyclic olefin copolymers (COC) to Polyplastics’ US slate of POM acetal polymers, PBT and PPS engineering resins. The combined business will be headquartered at Polyplastics’ US headquarters in Farmington Hills, Michigan.

The Japanese-owned plastics producer, which has held a stake in TOPAS for more than a decade, said the operations merger is a “key milestone” in its efforts to build a strong market presence in the Americas.

“We plan to leverage and further enhance TAP’s global leadership position in COC as Polyplastics moves forward to expand its market reach in the Americas,” Lindsey Deal, president of Polyplastics USA, and Timothy Kneale, president of TAP USA, said in a joint statement.

Polyplastics USA said it is retaining the majority of TAP USA’s personnel to ensure continuity for the growing number of COC customers in the packaging, healthcare, and other industries. For the high performance polymer business, the company said the merger “will deliver additional resources to support the strong growth of COC markets and applications” US sales of COC are said to have more than doubled since its Tokyo-based parent acquired the business in 2005.

The merger will not affect TAP’s Germany-based arm, which will continue to manufacture COC in Oberhausen, Germany, and handle sales for Europe, Middle East, and Africa (EMEA).

The company is regarded as the world’s leading manufacturer of COC, a glass-clear and extremely pure plastic for healthcare, packaging and electronics applications.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.